July 2023

Andy is currently the VP of Technical Development, Cell and Individualized Therapy at Genentech. He has held various CMC roles at Genentech, including leading the launches for POLIVY (anti-CD79b-vcMMAE ADC) and SUSVIMO (port delivery system for ranibizumab) as well as overseeing biologics bioprocess functions. Prior to Genentech, Andy held various positions in process development, analytical development and manufacturing at Cell Genesys, Inc. and Chiron Corp..  He received his Ph.D. in Biochemical Engineering from Northwestern ...Read more

John Mattila is Sr Director of Purification Process Development at Regeneron Pharmaceuticals, Inc., where he leads R&D purification spanning preclinical manufacturing to late-stage process definition.  John believes in the power of innovative medicines to improve lives, and he joined Regeneron so he could help bring important new medicines to patients.  His early years were at the bench developing purification processes for Fc-fusion proteins.  Since then, he has developed or overseen development of purification processes for nine FDA-...Read more

Qian Wang is an Associate Research Fellow and a Group Leader in the Analytical R&D group at Pfizer. Qian has over 15 years of experience in all aspect of analytical development for biopharmaceutics and vaccines. In her current role, Qian serves as analytical team leads to develop analytical strategies, enable process and product development, and support CMC regulatory strategies from toxicology through licensure. Qian holds a Ph.D. in analytical chemistry from University at Buffalo (SUNY) and a bachelor’s degree in chemistry from Fudan University, China.Read more

Rubi Burlage, Ph.D. is Associate Vice President, Sterile Product and Device Development at Merck & Co., Inc. In this role, Rubi is responsible for leadership of Merck’s sterile small molecule, biologics, and vaccine drug product design and development. In previous roles, Rubi has served as Executive Director, Sterile Drug Product Commercialization within Merck’s manufacturing division leading commercialization of Merck’s sterile therapeutic and vaccines drug products. Previously, Rubi has also led innovation in sterile and specialty products including...Read more